MedPath

Macrolane for Enhancement of the Shape and Fullness of the Female Breast

Not Applicable
Completed
Conditions
Breast Enhancement
Interventions
Device: Macrolane
Registration Number
NCT01308853
Lead Sponsor
Galderma R&D
Brief Summary

The study evaluates treatment procedure, efficacy and safety of Macrolane for female breast enhancement.

Detailed Description

This study evaluates the injection technique and treatment outcome by stepwise inclusion and treatment of Macrolane for female breast enhancement.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Female between 25 and 50 years of age with small breasts seeking enhancement of the shape and fullness of the breast
Exclusion Criteria
  • Unreasonable expectations
  • Any medical condition that may interfere with the treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MacrolaneMacrolaneOpen label
Primary Outcome Measures
NameTimeMethod
Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment6 weeks

Inclusion was made in steps in group of 4 subjects. The subjects were followed-up with MRI 1-5 days after the injection to document correct injection technique. Before the next group were treated, the Expert Group evaluated the 6-week follow-up results of the previous group. The injection procedure was, if necessary, changed in accordance with specifically pre-defined parameters.

Secondary Outcome Measures
NameTimeMethod
Percentage of Breasts With Improvement as Assessed by the Investigator6 weeks

Esthetic improvement was evaluated using the Global Esthetic Improvement Scale (GEIS).

The scale has five grades ranging from worse to very much improved. Subjects defined as "at least improved" are assessed as improved, much improved or very much improved.

© Copyright 2025. All Rights Reserved by MedPath